Serum Bile Acid Independently Predicts Liver Survival in Alagille Syndrome with Neonatal Cholestasis
A new study from the GALA cohort shows serum bile acid's association with clinical outcomes is relevant in the context of IBAT inhibitor therapy.
United States C Fiorella Murillo Perez Study Group Global Alagille Alliance Murillo Perez Cymabay Therapeutics
Source: hcplive.com